Next-Generation Sequencing: Solving the GenomeCHI Insight Pharma ReportsJune 1, 2009 164 Pages - SKU: CHI2390519 |
|
World Market for Personalized Medicine Diagnostics (Biomarkers, Pharmacodiagnostics, Tumor Assays, Cardiac Risk and Other Testing)
3/1/2012 | published by: Kalorama Information
In this market research report, Kalorama Information defines the current opportunity and a realistic future potential for personalized medicine in clinical testing. In addition to analysis of tests currently on the market and in development,
|
more...
|
$3,795.00
|
|
Next generation sequencing (NGS) market By Technology (Pyrosequencing & Others), Competitors (Illumina, 454 Roche, Life Science Technologies), Applications & Tools - Global Trends & Forecasts (2011 – 2016)
4/4/2012 | published by: MarketsandMarkets
Next generation sequencing is the next generation of DNA sequencing which includes several technologies to determine the order of nucleotide bases in a molecule of DNA. It is the fastest growing and the most lucrative
|
more...
|
$4,650.00
|
|
DNA Sequencing: Emerging Technologies and Applications
3/12/2012 | published by: BCC Research
The global market for sequencing products was nearly $3 billion in 2011, and it is forecast to grow at a compound annual growth rate (CAGR) of 17.5%
|
more...
|
$4,850.00
|
|
The World Market for Cancer Therapeutics and Biotherapeutics (Chemotherapy Agents, Interleukins/interferons, Monoclonal Antibodies, Hormone and Other Therapies), 4th Edition
1/1/2012 | published by: Kalorama Information
This Kalorama Information report - The World Market for Cancer Therapeutics and Biotherapeutics (Chemotherapy Agents, Interleukins/interferons, Monoclonal Antibodies, Hormone and Other Therapies) represents the fourth time that Kalorama Information has taken a comprehensive look at
|
more...
|
$3,500.00
|
|
Hospital-Acquired Infections: Diagnostic Markets and Testing Developments, Treatments, Key Competitors and Trends
7/1/2011 | published by: Kalorama Information
A hospital-acquired infection (HAI)is a new infection that develops in a patient during hospitalization. It is usually defined as an infection that is identified at least forty-eight to seventy-two hours following admission, so infections incubating,
|
more...
|
$3,995.00
|
|
Genetic Testing
2/1/2012 | published by: Global Industry Analysts
This report analyzes the worldwide markets for Genetic Testing in US$ Million. The US market is analyzed by the following Segments: Prenatal and Newborn Genetic Testing, Pharmacogenomic Testing, and Predictive testing. The report provides separate
|
more...
|
$4,500.00
|
|
Personalized Medicine Market Analysis
1/1/2012 | published by: RNCOS
With the increasing knowledge of human DNA, a new segment called personalized medicines has emerged in the healthcare industry, which includes therapeutics, diagnostics, and theranostics tailored towards the treatment or prevention of disease. Even though
|
more...
|
$1,200.00
|
|
Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
1/9/2012 | published by: GlobalData
Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Summary GlobalData’s new report, “Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017” provides key market data on
|
more...
|
$2,500.00
|
|
Gene Amplification Technologies
2/1/2012 | published by: Global Industry Analysts
This report analyzes the worldwide markets for Gene Amplification Technologies in US$ Million by the following Product Segments: Polymerase Chain Reaction, and Other Gene Amplification Technologies. The report provides separate comprehensive analytics for the US,
|
more...
|
$4,500.00
|
|
Biomarkers Market Discovery Technologies (Proteomics, Genomics, Imaging, Bioinformatics), Applications (Drug Discovery, Personalized Medicine, Molecular Diagnostics) & Indications (Cancer, Cardiovascular & Neural) Global Trends & Forecasts (2011 - 2020)
2/2/2012 | published by: MarketsandMarkets
A biomarker is defined as a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic response to a therapeutic intervention. Biomarkers are classified in different ways
|
more...
|
$4,650.00
|
Related Markets
DNA Sequencing Reports
- Next generation sequencing (NGS) market By Technology (Pyrosequencing & Others), Competitors (Illumina, 454 Roche, Life Science Technologies), Applications & Tools - Global Trends & Forecasts (2011 – 2016)
- DNA Sequencing: Emerging Technologies and Applications
- Next Generation Sequencing: Market Size, Segmentation, Growth and Trends by Provider
- The Global Outlook for Next Generation Sequencing: Usage, Platform Drivers & Workflow
- End-user Trends in the U.S. Next-Generation Sequencing Market
